Title: Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.
Journal: Bioorganic & medicinal chemistry 20111101
5221-44-3
13160-61-7
57806-32-3
315240-54-1
1793108-54-9 | tert-butyl 3-oxo-8-azaspiro[4.5]dec-1-ene-8-carboxylate | AA01EA6H | MFCD31667558
2122333-63-3 | Tenofovir diphosphate triethylamine salt | AA01EALE
1903008-80-9 | Lazertinib | AA01EAZH | MFCD31728331
38805-90-2 | (1R,2S)-2-phenylcyclopentanol | AA01EB77 | MFCD19237780
1932445-99-2 | Trans-tert-butyl (3aR,9bR)-1,3,3a,4,5,9b-hexahydropyrrolo[3,4-c]quinoline-2-carboxylate | AA01EE5S | MFCD14581151
3397-23-7 | Ornipressin | AA01EFMN | MFCD16659865
91420-23-4 | 5-Chloro-2-methylpyridin-3-ol | AA01EH6F | MFCD18205865
1098366-68-7 | 4-[(Dimethylsulfamoyl)methyl]benzoic acid | AA01EH99 | MFCD11647510
2096341-45-4 | 2,4-Difluoro-3-(2-methoxyethoxy)-5-methylphenylboronic acid | AA01EHCM | MFCD20441788
2096340-08-6 | 4-(Benzyloxy)-3-chloro-5-fluorophenylboronic acid | AA01EHFK | MFCD20441806